|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Integrated data from 2 randomized, double - blind, placebo - controlled, phase 3 trials of active cellular immunotherapy with sipuleucel - T in ad- vanced prostate cancer 显示文摘 | Higano CS Schellhammer PF Small E J | 2009 | Cancer2009，115，16： | 1 |
| 2 | Integrated analysis of pharmacokinetic data across multiple clinical pharmacology studies of prasugrel,a new thienopyridine antiplatelet agent显示文摘 | Small DS Li YG Ernest CS 2nd | | 0，，： | 1 |
| 3 | Place bo-controlled Phase Ⅲ Trial of immunologic therapy with Sipuleucel-T (APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘 | SMALL E SCHELLHAMMER PF HIGANO Cs | 2006 | J Clin Oncol2006，24，19： | 1 |
| 4 | Placebo-controlledphaseⅢtrial of immunologic therapy with sipuleucel-T(APC8015)in patients with metastatic,asymptomatic hormone re-fractory prostate cancer显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 5 | Sipuleu-cel-T显示文摘 | HIGANO CS SMALL EJ SCHELLHAMMER P | 2010 | A^ai Rev Drug Discov2010，9，7： | 1 |
| 6 | Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small E J Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 7 | Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T(APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 8 | Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘 | Small E J Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，： | 1 |
| 9 | Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small E J Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，： | 1 |
| 10 | Placebocontrolled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small EJ Sehellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 11 | Placebo-con- trolled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 12 | Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 tri- als of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer 显示文摘 | Higano CS Schellhammer PF Small E J | 2009 | Cancer2009，115，16： | 1 |
| 13 | Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease显示文摘 | Small DS Wrishko RE Ernest CS | 2009 | Clin Pharm Ther2009，34，5： | 1 |
| 14 | Placebo-con trolled phase III trial of immunologic therapy with sipuleucelT (APC8015) in patients with metastatic, asymptomatic hor mone refractory prostate cancer显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 15 | Integrated datafrom 2 randomized,double-blind,placebo-controlled,phaseⅢtrials of active cellular immunotherapy with sipuleucel-T in ad-vanced prostate cancer显示文摘 | Higano CS Schellhammer PF Small EJ | 2009 | Cancer2009，115，16： | 1 |
| 16 | Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T(APC8015)in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 17 | Placebo-controlled phaseⅢtrial of immunologic therapy with sipuleucel-T(APC8015)in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 18 | Placebo- controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small EJ Schellhammer PF Higano CS | 2006 | J Clin Oncol2006，24，19： | 1 |
| 19 | Integrated data from 2 randomized, double-blind, placebo-controlled, Phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer 显示文摘 | Higano CS Schellhammer PF Small E J | 2009 | Cancer2009，115，16： | 1 |
| 20 | Sipuleueel-T 显示文摘 | Higano CS Small EJ Schellhammer P | 2010 | Nat Rev Drug Discov2010，9，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员